Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$461M |
| 2 |
American Tower
AMT
|
+$401M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$399M |
| 4 |
US Bancorp
USB
|
+$346M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$589M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$506M |
| 3 |
Lockheed Martin
LMT
|
+$418M |
| 4 |
RTN
Raytheon Company
RTN
|
+$373M |
| 5 |
Procter & Gamble
PG
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.78% |
| 2 | Healthcare | 12.43% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPZM
1726
DELISTED
Epizyme, Inc
EPZM
| $8.7M | ﹤0.01% |
541,416
+60,962
| +13% | +$1.06M |
|
|
MINI
1727
DELISTED
Mobile Mini Inc
MINI
| $8.7M | ﹤0.01% |
294,754
-111,072
| -27% | -$3.31M |
|
|
ESPR
1728
DELISTED
Esperion Therapeutics
ESPR
| $8.68M | ﹤0.01% |
169,202
-14,529
| -8% | -$608K |
|
1729
Acco Brands
ACCO
$401M
| $8.68M | ﹤0.01% |
1,222,308
-118,597
| -9% | -$738K |
|
1730
Park National Corp
PRK
$3.77B
| $8.67M | ﹤0.01% |
123,191
+2,144
| +2% | +$157K |
|
1731
Check Point Software Technologies
CHKP
$12.6B
| $8.64M | ﹤0.01% |
80,440
-6,816
| -8% | -$722K |
|
|
RDUS
1732
DELISTED
Radius Recycling
RDUS
| $8.63M | ﹤0.01% |
489,163
-39,597
| -7% | -$612K |
|
|
SASR
1733
DELISTED
Sandy Spring Bancorp Inc
SASR
| $8.62M | ﹤0.01% |
347,870
+108,039
| +45% | +$2.57M |
|
1734
Griffon
GFF
$4.11B
| $8.62M | ﹤0.01% |
465,442
-47,675
| -9% | -$777K |
|
|
GLUU
1735
DELISTED
Glu Mobile Inc.
GLUU
| $8.61M | ﹤0.01% |
929,212
+208,078
| +29% | +$1.77M |
|
1736
Virtu Financial
VIRT
$5.04B
| $8.59M | ﹤0.01% |
364,034
+53,072
| +17% | +$1.24M |
|
1737
First Interstate BancSystem
FIBK
$3.74B
| $8.59M | ﹤0.01% |
277,271
+33,399
| +14% | +$1.02M |
|
1738
Pilgrim's Pride
PPC
$6.64B
| $8.58M | ﹤0.01% |
508,168
-59,288
| -10% | -$1.16M |
|
1739
Kadant
KAI
$3.85B
| $8.58M | ﹤0.01% |
86,080
+9,608
| +13% | +$855K |
|
1740
Veracyte
VCYT
$3.65B
| $8.58M | ﹤0.01% |
331,176
-30,990
| -9% | -$772K |
|
1741
BILL Holdings
BILL
$4.73B
| $8.57M | ﹤0.01% |
+95,013
| New | +$6.12M |
|
1742
Trupanion
TRUP
$1.09B
| $8.54M | ﹤0.01% |
199,972
+13,981
| +8% | +$452K |
|
|
PTLA
1743
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $8.49M | ﹤0.01% |
472,129
+19,653
| +4% | +$273K |
|
|
ADAM
1744
Adamas Trust
ADAM
$845M
| $8.45M | ﹤0.01% |
809,411
+71,545
| +10% | +$627K |
|
1745
BridgeBio Pharma
BBIO
$15.7B
| $8.43M | ﹤0.01% |
258,411
+3,693
| +1% | +$112K |
|
|
ONEM
1746
DELISTED
1Life Healthcare
ONEM
| $8.41M | ﹤0.01% |
231,436
+190,600
| +467% | +$5.37M |
|
1747
Karyopharm Therapeutics
KPTI
$45.3M
| $8.4M | ﹤0.01% |
29,581
+3,838
| +15% | +$1.14M |
|
1748
NMI Holdings
NMIH
$3.34B
| $8.4M | ﹤0.01% |
522,478
+8,256
| +2% | +$117K |
|
1749
MBIA
MBI
$270M
| $8.38M | ﹤0.01% |
1,155,614
-323,709
| -22% | -$2.35M |
|
1750
Bilibili
BILI
$8.09B
| $8.37M | ﹤0.01% |
180,604
+117,465
| +186% | +$3.81M |
|
Similar funds
Charles Schwab's Q2 2020 Portfolio in Review
As of Q2 2020, Charles Schwab held 3,435 positions worth $204B, up 20% from $170B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2020 filing shows 201 new, 1,862 increased, 1,124 reduced and 116 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M. The largest sale was Intel, an estimated $589M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2020 buy was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M.
- Charles Schwab added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $461M increase.
- Charles Schwab's biggest Q2 2020 reduction was Intel, cutting an estimated $589M.
- Charles Schwab fully exited Raytheon Company in Q2 2020, selling an estimated $373M.
- Charles Schwab's ten largest holdings make up 17% of its $204B portfolio in Q2 2020.
- Charles Schwab opened 201 new positions and closed 116 in Q2 2020.
- Charles Schwab's portfolio value rose 20% quarter-over-quarter to $204B.
Based on Charles Schwab's 13F filing for Q2 2020, filed 14 Aug 2020.